# DEXTROSE 5% AND LACTATED RINGER'S
> **ANDA210332** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-03-28
## Drug
- **FDA Application Number:** ANDA210332
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROSE 5% AND LACTATED RINGER'S
- **Generic name:** SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE
- **Active ingredients:** CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210332)
---
*AI Analytics · CC0 1.0*